Liberty All-Star Equity Fund(USA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

USA Liberty All-Star Equity Fund

未开盘 03-24 16:00:00 EDT

5.59

-0.02

-0.36%

盘后5.59

+0.00+0.04%

17:53 EDT

最高5.61	最低5.55	成交量128.13万
今开5.58	昨收5.61	日振幅1.07%
总市值16.86亿	流通市值16.86亿	总股本3.02亿
成交额715.88万	换手率0.42%	流通股本3.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"USA","market":"US","secType":"STK","nameCN":"Liberty All-Star Equity Fund","latestPrice":5.59,"timestamp":1774382400000,"preClose":5.61,"halted":0,"volume":1281264,"hourTrading":{"tag":"盘后","latestPrice":5.592,"preClose":5.59,"latestTime":"17:53 EDT","volume":198258,"amount":1108662.151,"timestamp":1774389197510,"change":0.002,"changeRate":0.000358,"amplitude":0.000358},"delay":0,"changeRate":-0.0035650623885918825,"floatShares":301551615,"shares":301551615,"eps":0.556777,"marketStatus":"未开盘","change":-0.02,"latestTime":"03-24 16:00:00 EDT","open":5.58,"high":5.61,"low":5.55,"amount":7158809.806612801,"amplitude":0.010695,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.556777,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":5.61,"dividendRate":0.121646,"preHourTrading":{"tag":"盘前","latestPrice":5.61,"preClose":5.61,"latestTime":"08:12 EDT","volume":231,"amount":1295.526309,"timestamp":1774354349508,"change":0,"changeRate":0,"amplitude":0.004456},"postHourTrading":{"tag":"盘后","latestPrice":5.592,"preClose":5.59,"latestTime":"17:53 EDT","volume":198258,"amount":1108662.151,"timestamp":1774389197510,"change":0.002,"changeRate":0.000358,"amplitude":0.000358},"volumeRatio":1.224372},"requestUrl":"/m/hq/s/USA","defaultTab":"news","newsList":[{"id":"1157135932","title":"Apogee Therapeutics公布3.5亿美元承销公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1157135932","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157135932?lang=zh_cn&edition=full","pubTime":"2026-03-25 09:55","pubTimestamp":1774403756,"startTime":"0","endTime":"0","summary":"旧金山和波士顿，2026年3月24日——临床阶段生物技术公司Apogee Therapeutics, Inc.今日宣布，其先前公布的承销公开发行已完成定价。此次发行以每股70.00美元的公开发行价格，共计发行5,000,000股普通股。在扣除承销折扣、佣金以及Apogee应承担的其他发行费用之前，公司预计从此次发行中获得的总收益约为3.5亿美元。此外，Apogee已授予承销商一项为期30天的选择权，允许其以公开发行价额外购买最多750,000股普通股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","USA","AD","BK4132","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2603659258","title":"Mdxhealth Sa盘中异动 早盘大幅拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603659258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603659258?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:19","pubTimestamp":1768321147,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日00时19分，Mdxhealth Sa股票出现异动，股价急速上涨5.54%。Mdxhealth Sa股票所在的生命科学行业中，整体跌幅为0.22%。其相关个股中，Revvity, Inc.、Mdxhealth Sa、Biodesix, Inc.涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为14.49%、13.35%、1.62%，振幅较大的相关个股有Ispecimen Inc.、Biodesix, Inc.、Precipio, Inc.，振幅分别为26.46%、17.88%、12.51%。Mdxhealth Sa公司简介：MDxHealth SA 是一家跨国医疗保健公司，提供可作的分子诊断信息，以个性化癌症的诊断和治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114001907953ca0b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114001907953ca0b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","MDXH","BDSX","BK4139","USA"],"gpt_icon":0},{"id":"1173182408","title":"Monte Rosa Therapeutics宣布拟公开发行普通股及预融资权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1173182408","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173182408?lang=zh_cn&edition=full","pubTime":"2026-01-08 05:02","pubTimestamp":1767819763,"startTime":"0","endTime":"0","summary":"2026年1月7日，临床阶段生物技术公司Monte Rosa Therapeutics宣布启动承销公开发行，计划募集2亿美元资金。本次发行将包含公司普通股股份，并对特定投资者提供可认购普通股的预融资权证作为替代选择。所有发售股份及权证均由Monte Rosa提供。该公司同时授予承销商30天超额配售选择权，可额外认购最多3000万美元普通股。详细风险因素载于公司最新10-K年报及10-Q季报，Monte Rosa明确声明不承担更新前瞻性陈述的义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4099","BK4139","BK4585","TM","USA","BK4604","GLUE","03160","BK4555","BK4539"],"gpt_icon":0},{"id":"1126414242","title":"新闻稿：Terns宣布拟进行公开募股","url":"https://stock-news.laohu8.com/highlight/detail?id=1126414242","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126414242?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:15","pubTimestamp":1765278930,"startTime":"0","endTime":"0","summary":"加利福尼亚州福斯特城，2025年12月9日-- Terns Pharmaceuticals, Inc.，一家处于临床阶段的肿瘤学公司，今日宣布已开始进行4亿美元普通股的承销公开募股，并向某些投资者提供购买普通股的预售认购权证。此外，Terns预计将授予承销商一个30天的选择权，可以根据公开募股价格额外购买最多6000万美元的普通股。所有将在此次募股中售出的普通股和预售认购权证均将由Terns提供。此次募股受市场及其他条件的影响，无法保证该募股是否及何时会完成，或其实际规模和条款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TERN","BK4007","USA"],"gpt_icon":0},{"id":"1139656680","title":"新闻稿：Olema Oncology宣布成功完成2.185亿美元的普通股公开发行，并全额行使承销商增购股份的选项","url":"https://stock-news.laohu8.com/highlight/detail?id=1139656680","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139656680?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:03","pubTimestamp":1763672604,"startTime":"0","endTime":"0","summary":"旧金山，2025年11月20日-- Olema Pharmaceuticals, Inc.是一家临床阶段生物制药公司，专注于乳腺癌及其他领域的靶向治疗的发现、开发和商业化。今天，该公司宣布完成其先前公告的1150万股普通股的承销公开发行，其中包括承销商全额行使增购150万股普通股的选项，公众发行价为每股19.00美元。Olema通过此次发行获得的总收益约为2.185亿美元。关于此次发行的最终招股说明书补充文件及相关招股说明书可通过SEC网站www.sec.gov免费获取。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.all-starfunds.com","stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":-0.073},{"period":"3month","weight":-0.1155},{"period":"6month","weight":-0.1224},{"period":"1year","weight":-0.1669},{"period":"ytd","weight":-0.1099}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liberty All Star Equity Fund是马萨诸塞州的一家商业信托公司，根据1940年《投资公司法》（\"1940年法案\"）及其修订版注册，是一家多元化的封闭式管理投资公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.010662},{"month":2,"riseRate":0.475,"avgChangeRate":-0.000234},{"month":3,"riseRate":0.55,"avgChangeRate":0.000992},{"month":4,"riseRate":0.538462,"avgChangeRate":0.00974},{"month":5,"riseRate":0.538462,"avgChangeRate":-0.0042},{"month":6,"riseRate":0.538462,"avgChangeRate":0.005641},{"month":7,"riseRate":0.538462,"avgChangeRate":0.008018},{"month":8,"riseRate":0.410256,"avgChangeRate":-0.020782},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.009212},{"month":10,"riseRate":0.487179,"avgChangeRate":-0.003123},{"month":11,"riseRate":0.6,"avgChangeRate":-0.00139},{"month":12,"riseRate":0.625,"avgChangeRate":0.007434}],"exchange":"NYSE","name":"Liberty All-Star Equity Fund","nameEN":"Liberty All-Star Equity"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liberty All-Star Equity Fund(USA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liberty All-Star Equity Fund(USA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liberty All-Star Equity Fund,USA,Liberty All-Star Equity Fund股票,Liberty All-Star Equity Fund股票老虎,Liberty All-Star Equity Fund股票老虎国际,Liberty All-Star Equity Fund行情,Liberty All-Star Equity Fund股票行情,Liberty All-Star Equity Fund股价,Liberty All-Star Equity Fund股市,Liberty All-Star Equity Fund股票价格,Liberty All-Star Equity Fund股票交易,Liberty All-Star Equity Fund股票购买,Liberty All-Star Equity Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liberty All-Star Equity Fund(USA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liberty All-Star Equity Fund(USA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}